Active Ingredient History
Epoetin beta (INN), sold under the brand name Neorecormon among others, is a synthetic, recombinant form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia (Phase 4)
Diabetes Mellitus (Phase 3)
Dialysis (Phase 3)
Drugs, Generic (Phase 4)
Fatigue (Phase 2)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
HIV Infections (Phase 4)
Ischemia (Phase 3)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Transplantation (Phase 4)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Lymphoma (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 4)
Myocardial Ischemia (Phase 2)
Neoplasms (Phase 3)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 3)
Uterine Cervical Neoplasms (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue